Afamelanotide and Narrow-Band Ultraviolet B (NB-UVB) Phototherapy in the Treatment of Nonsegmental Vitiligo (NSV)
Study sponsor: Clinuvel Pharmaceuticals Limited
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2016-02-02Actual
Enrollment · participants21Actual
Source updated2023-09-22Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.